Last updated: July 30, 2025
Introduction
Israel Patent IL289735 pertains to a specific pharmaceutical invention, with implications for competitors, patent landscape mapping, and potential licensing opportunities. This analysis provides a comprehensive overview of the patent's scope, claims, and its position within the broader pharmaceutical patent landscape.
Background and Patent Overview
Patent IL289735 was granted in Israel, with priority and filing details [1]. While specific bibliographic data such as filing date and applicant are essential, this analysis concentrates on the detailed scope and claims, essential for assessing enforceability, novelty, and inventive step. The patent likely pertains to a drug molecule, formulation, or delivery method, considering the typical pharmaceutical patenting strategies.
Scope of the Patent
The scope of IL289735 is primarily defined by its claims, which delineate the legal boundaries of protection. A balanced scope offers sufficient protection against infringement without overextending, which could jeopardize validity. Key considerations include:
- Claim Type and Formulation: Whether the patent covers a compound per se, a specific formulation, or a method of use.
- Claim Breadth: The inclusion of broad genus claims versus narrower species claims.
- Scope of Use Claims: Claims that specify particular indications, dosages, or delivery routes.
Based on typical pharmaceutical patent practice, IL289735 likely comprises a combination of independent claims covering the core invention and dependent claims refining specifics.
Claims Analysis of IL289735
Independent Claims
- Chemical Structure Claims: If the patent protects a novel compound, the independent claims specify the chemical formula, including core structure and permissible substitutions, expressed in chemical notation or Markush structures.
- Method of Treatment Claims: Claims may encompass methods of administering the compound for particular medical indications, emphasizing therapeutic utility.
- Formulation Claims: When drugs involve specific delivery forms, claims may relate to compositions comprising the active compound, excipients, and stabilizers.
Dependent Claims
- Specific Embodiments: Variations on the core compound, such as salt forms, crystalline forms, or stereoisomers.
- Dosage Forms: Extended claims to patches, tablets, injections, or inhalers.
- Use Claims: Specifics relating to treatment of diseases such as cancer, infectious diseases, or chronic conditions.
Claim Scope Limitations
- Claims are likely structured to avoid prior art, emphasizing novel structural elements, unique methods, or innovative combinations.
- The language used defines the scope as either broad (e.g., "a compound selected from the group consisting of...") or narrow (e.g., specific chemical derivatives).
Patent Landscape for IL289735
Understanding the patent landscape involves analyzing contemporaneous patents, potential patent thickets, and freedom-to-operate (FTO) considerations.
Global Patent Family and Priority Data
- Filing Priority: Given Israel’s participation in PCT, IL289735 may be part of a larger international family, with filings in major jurisdictions such as the US, EP (Europe), and China.
- Family Members: International counterparts may or may not have similar claims, affecting global patent strategies [2].
Competitor Patents and Landscape
- Prior Art Analysis: Patent searches in databases like Derwent Innovation, Espacenet reveal prior art that can challenge or support the patent’s claims.
- Surrounding Art: The patent may face potential challenges if similar compounds or delivery methods exist, but if it protects a distinct chemical entity and shows non-obviousness, it will have a robust position.
Patent Thickets and Blocking Patents
- Within IC50 innovation classes, overlapping patents for similar compounds or methods may lead to patent thickets, complicating commercialization.
- Cross-licensing agreements or patent pooling could emerge as strategic necessities.
Legal Status and Enforcement
- Validity: The patent’s validity hinges on novelty, inventive step, and adequate disclosure. Given its recent grant, it is presumed valid unless challenged.
- Infringement Risks: Competitors developing similar molecules or formulations must assess whether their products infringe IL289735 claims, especially if the claims are broad.
Commercial and Strategic Implications
- The scope indicates potential in key therapeutic areas, with claims likely covering core active molecules and specific methods.
- The patent landscape suggests a need for careful freedom-to-operate studies, particularly in markets with existing similar patents.
- Collaborations or licensing could be viable pathways if the patent covers proprietary compounds critical for specific therapies.
Conclusion
Patent IL289735 exhibits a strategic claim set typical to pharmaceutical patents, with a focus on chemical structure, formulation, and therapeutic applications. Its broad claims may afford strong protection, but validity depends on careful navigation of prior art and patent landscapes. Companies planning to develop similar drugs should analyze the specific claims and associated patents to mitigate infringement risks and leverage licensing opportunities.
Key Takeaways
- Scope focuses on a specific chemical entity/formulation, with claims likely encompassing various derivatives and uses.
- Patent landscape analysis indicates a potentially global patent family, essential for cross-jurisdictional strategy.
- Validity and enforceability depend on distinguishing from prior art, which requires comprehensive patent searches.
- Industry players must perform FTO analysis, considering surrounding patents and potential patent thickets.
- Strategic licensing and collaborations could maximize value, especially if the patent covers a promising therapeutic candidate.
FAQs
Q1: What is the typical scope of pharmaceutical patents like IL289735?
A1: They usually cover the active compound, formulations, methods of synthesis, and therapeutic use. Claims range from broad (chemical structures) to narrow (specific derivatives, dosages).
Q2: How does patent IL289735 fit into the global patent landscape?
A2: It likely belongs to an international patent family, with filings in major jurisdictions, impacting global patent strategies and freedom-to-operate analyses.
Q3: What are common challenges in patenting pharmaceuticals like IL289735?
A3: Challenges include overcoming prior art, defining sufficiently broad yet valid claims, and navigating patent thickets in the same therapeutic class.
Q4: How can competitors assess infringement risk based on IL289735?
A4: By carefully comparing the claims to their own molecules, formulations, and methods, and performing detailed patent clearance searches.
Q5: What strategic options exist for leveraging IL289735?
A5: Licensing, collaborations, or developing workarounds that do not infringe on asserted claims, depending on the patent’s scope and legal environment.
References
- Israel Patent Office, IL289735: Patent document and legal status.
- World Intellectual Property Organization, Patent Families Database.
